Episode 101: Colorectal Cancer Series, Pt. 3 - Adjuvant Therapy in Stage II Colon Cancer and ctDNA

The Fellow on Call: The Heme/Onc Podcast

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago

MP3•Episode home

In this week’s episode, we discuss the management of stage II colon adenocarcinoma, which is defined by a lack of nodal involvement and invasion through the muscularis layer of the colon. If you have not done so already, be sure to check out episode 099 (overview of colorectal cancer) and episode 100 for stage III colon cancer, as we will building on concepts discussed already.

Content:

- Is there a role for adjuvant chemotherapy in stage II colon cancer patients?

- What is the impact on MSI/MMR testing in stage II colon cancer patients?

- Is there a role for evaluating circulating tumor DNA (ctDNA) in colon cancer patients?

- Is there a role for immunotherapy in the adjuvant setting?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

114 episodes

#Ronak Mistry #Rouleaux University Medical Center #Science #Fitness #Biology #Podcasting Education #Medicine #Lung Cancer